BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 29848970)

  • 1. Circulating Cell-Free DNA as a Prognostic and Molecular Marker for Patients with Brain Tumors under Perillyl Alcohol-Based Therapy.
    Faria G; Silva E; Da Fonseca C; Quirico-Santos T
    Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29848970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of monoterpene perillyl alcohol upon survival rate of patients with recurrent glioblastoma.
    da Fonseca CO; Simão M; Lins IR; Caetano RO; Futuro D; Quirico-Santos T
    J Cancer Res Clin Oncol; 2011 Feb; 137(2):287-93. PubMed ID: 20401670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal perillyl alcohol therapy improves survival of patients with recurrent glioblastoma harboring mutant variant for MTHFR rs1801133 polymorphism.
    Faria GM; Soares IDP; D'Alincourt Salazar M; Amorim MR; Pessoa BL; da Fonseca CO; Quirico-Santos T
    BMC Cancer; 2020 Apr; 20(1):294. PubMed ID: 32264844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ras pathway activation in gliomas: a strategic target for intranasal administration of perillyl alcohol.
    da Fonseca CO; Linden R; Futuro D; Gattass CR; Quirico-Santos T
    Arch Immunol Ther Exp (Warsz); 2008; 56(4):267-76. PubMed ID: 18726148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcome in patients with recurrent malignant glioma treated with Perillyl alcohol inhalation.
    DA Fonseca CO; Teixeira RM; Silva JC; DE Saldanha DA Gama Fischer J; Meirelles OC; Landeiro JA; Quirico-Santos T
    Anticancer Res; 2013 Dec; 33(12):5625-31. PubMed ID: 24324108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic and Prognostic Value of Circulating DNA Fragments in Glioblastoma Multiforme Patients.
    Jarmuzek P; Wawrzyniak-Gramacka E; Morawin B; Tylutka A; Zembron-Lacny A
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of tumor topography and peritumoral edema of recurrent malignant gliomas with therapeutic response to intranasal administration of perillyl alcohol.
    Da Fonseca CO; Silva JT; Lins IR; Simão M; Arnobio A; Futuro D; Quirico-Santos T
    Invest New Drugs; 2009 Dec; 27(6):557-64. PubMed ID: 19139816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of EGF+61A>G polymorphism and EGF serum levels in Brazilian glioma patients treated with perillyl alcohol-based therapy.
    da Silveira Fd; Lopes Bde A; da Fonseca CO; Quirico-Santos T; de Palmer Paixão IC; de Amorim LM
    J Cancer Res Clin Oncol; 2012 Aug; 138(8):1347-54. PubMed ID: 22481252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in the molecular genetics of malignant gliomas disclose targets for antitumor agent perillyl alcohol.
    da Fonseca CO; Landeiro JA; Clark SS; Quirico-Santos T; da Costa Carvalho Mda G; Gattass CR
    Surg Neurol; 2006; 65 Suppl 1():S1:2-1:8; discussion S1:8-1:9. PubMed ID: 16427438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary results from a phase I/II study of perillyl alcohol intranasal administration in adults with recurrent malignant gliomas.
    da Fonseca CO; Schwartsmann G; Fischer J; Nagel J; Futuro D; Quirico-Santos T; Gattass CR
    Surg Neurol; 2008 Sep; 70(3):259-66; discussion 266-7. PubMed ID: 18295834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of circulating DNA in malignant neoplasia from diverse locations: Investigating a diagnostic role.
    Kumari S; Mishra S; Husain N; Verma T; Tiwari V; Kaif M; Agarwal A; Rastogi M; Shukla S; Sonkar AA
    Indian J Pathol Microbiol; 2022; 65(1):93-99. PubMed ID: 35074971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perillyl alcohol, a pleiotropic natural compound suitable for brain tumor therapy, targets free radicals.
    Gomes AC; Mello AL; Ribeiro MG; Garcia DG; Da Fonseca CO; Salazar MD; Schönthal AH; Quirico-Santos T
    Arch Immunol Ther Exp (Warsz); 2017 Aug; 65(4):285-297. PubMed ID: 28314870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anaplastic oligodendroglioma responding favorably to intranasal delivery of perillyl alcohol: a case report and literature review.
    Da Fonseca CO; Masini M; Futuro D; Caetano R; Gattass CR; Quirico-Santos T
    Surg Neurol; 2006 Dec; 66(6):611-5. PubMed ID: 17145324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal administration of the chemotherapeutic perillyl alcohol results in selective delivery to the cerebrospinal fluid in rats.
    Nehra G; Andrews S; Rettig J; Gould MN; Haag JD; Howard SP; Thorne RG
    Sci Rep; 2021 Mar; 11(1):6351. PubMed ID: 33737566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma.
    Wang ZQ; Zhang MY; Deng ML; Weng NQ; Wang HY; Wu SX
    PLoS One; 2017; 12(9):e0184969. PubMed ID: 28931080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perillyl alcohol induces apoptosis in human glioblastoma multiforme cells.
    Fernandes J; da Fonseca CO; Teixeira A; Gattass CR
    Oncol Rep; 2005 May; 13(5):943-7. PubMed ID: 15809762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-thrombin as a prognostic biomarker candidate for patients with recurrent glioblastoma multiform under treatment with perillyl alcohol.
    Fischer Jde S; Carvalho PC; Neves-Ferreira AG; da Fonseca CO; Perales J; Carvalho Mda G; Domont GB
    J Exp Ther Oncol; 2008; 7(4):285-90. PubMed ID: 19227008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma Cell-Free DNA as a Predictive Marker after Radiotherapy for Hepatocellular Carcinoma.
    Park S; Lee EJ; Rim CH; Seong J
    Yonsei Med J; 2018 Jun; 59(4):470-479. PubMed ID: 29749129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of GSTM1 and GSTT1 polymorphisms on the survival rate of patients with malignant glioma under perillyl alcohol-based therapy.
    Silva MM; Da Fonseca CO; Moura-Neto R; Carvalho JF; Quirico-Santos T; Carvalho MG
    Genet Mol Res; 2013 May; 12(2):1621-30. PubMed ID: 23765968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy.
    Coco S; Alama A; Vanni I; Fontana V; Genova C; Dal Bello MG; Truini A; Rijavec E; Biello F; Sini C; Burrafato G; Maggioni C; Barletta G; Grossi F
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28492516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.